A number of models to predict the prognosis of NB, including MYCN-related signatures (Wang et al., 2020), hypoxia gene signatures (Fardin et al., 2010), and immune-based models (Song et al., 2020), have been reported. This evidence concerns the gene MYCN and neuroblastoma.